LZIP Activators refers to a class of chemical compounds that influence the activation of the LZIP protein indirectly through modulation of cellular stress response pathways. These activators work by triggering intracellular signaling cascades that culminate in the functional engagement of LZIP, a transcription factor involved in managing cellular responses to stress, particularly the unfolded protein response. The compounds vary in their mechanism of action, including the alteration of cAMP levels, modulation of calcium signaling, induction of ER stress by inhibiting glycosylation or Ca2+ ATPases, or disrupting protein transport mechanisms. These various biochemical actions converge on the enhancement of the UPR, which can have downstream effects on the functional state of LZIP.
The chemical compounds classed as indirect activators of LZIP do not interact directly with the protein but exert their influence through perturbations of cellular homeostasis. For instance, agents like Forskolin, 2-Aminoethoxydiphenyl borate, Thapsigargin, Tunicamycin, and Brefeldin A represent diverse chemical structures including diterpenes, borate compounds, sesquiterpene lactones, nucleoside antibiotics, and fungal metabolites, respectively. Despite their structural diversity, their functional end-point-modulation of stress pathways that can affect LZIP's role in transcriptional regulation-provides a commonality that defines their collective characterization as LZIP Activators. This intricate connection emphasizes the importance of cellular context in determining the impact of a chemical on the activity of a specific protein such as LZIP.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin is a diterpene produced by the Indian Coleus plant. It activates adenylate cyclase, increasing cAMP levels in cells. This elevation in cAMP can enhance protein kinase A (PKA) activity, which may phosphorylate factors that modulate the UPR, potentially impacting LZIP activity. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
This compound is a modulator of inositol 1,4,5-trisphosphate receptors and can alter calcium signaling in cells. Calcium fluxes are known to be intricate components of various cellular signaling pathways, including those that regulate the UPR. Through this modulation, it might affect the activity of transcription factors like LZIP. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin is a sesquiterpene lactone that inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to an increase in cytosolic calcium levels. This disrupts calcium homeostasis and can activate the UPR, potentially influencing LZIP activity. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $169.00 $299.00 | 66 | |
Tunicamycin is a nucleoside antibiotic that inhibits N-linked glycosylation in the ER, leading to the accumulation of misfolded proteins and the activation of the UPR. This stress response may, in turn, modulate the activity of LZIP. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A is a fungal metabolite that inhibits protein transport from the ER to the Golgi apparatus, causing ER stress and potentially triggering the UPR. This might have downstream effects on LZIP activation. |